TickerFactsScreenerDevelopers

Lantern Pharma Inc. (LTRN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$2.13M2020: -$5.65M2021: -$10.59M2022: -$12.77M2023: -$14.35M2024: -$17.81M2025: -$15.68M-$15.68M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$15.68M+12.0%
2024-$17.81M-24.2%
2023-$14.35M-12.4%
2022-$12.77M-20.5%
2021-$10.59M-87.4%
2020-$5.65M-165.6%
2019-$2.13M—